Literature DB >> 8506784

A proposed revision of the Fagerstrom Tolerance Questionnaire.

J C Tate1, J M Schmitz.   

Abstract

This article presents the results of initial testing of a revised version of the Fagerstrom Tolerance Questionnaire (TQ). Revisions were designed to improve the psychometric properties of the TQ. Four diverse samples of cigarette smokers completed the 10-item Revised Tolerance Questionnaire (RTQ), and responses were subjected to psychometric and factor analyses. Substantial improvement in internal consistency was obtained as compared to prior studies of the TQ. In addition, the results of factor analysis indicate that a substantial amount of covariation among the 10 items can be accounted for by a single common factor. Thus, unlike the TQ, the RTQ appears to be measuring a unidimensional construct. Also, preliminary data on temporal stability are positive. With respect to validity, the RTQ correlated moderately with the TQ and outperformed the TQ in predicting expired alveolar carbon monoxide. Finally, suggestions for further establishing the validity of the RTQ are offered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506784     DOI: 10.1016/0306-4603(93)90043-9

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  9 in total

1.  Adherence to nicotine replacement therapy among pregnant smokers.

Authors:  Laura J Fish; Bercedis L Peterson; Rebecca J Namenek Brouwer; Pauline Lyna; Cheryl A Oncken; Geeta K Swamy; Evan R Myers; Pamela K Pletsch; Kathryn I Pollak
Journal:  Nicotine Tob Res       Date:  2009-04-07       Impact factor: 4.244

2.  Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST.

Authors:  R P Schwartz; J McNeely; L T Wu; G Sharma; A Wahle; C Cushing; C D Nordeck; A Sharma; K E O'Grady; J Gryczynski; S G Mitchell; R L Ali; J Marsden; G A Subramaniam
Journal:  J Subst Abuse Treat       Date:  2017-01-31

3.  Efficacy of a Texting Program to Promote Cessation Among Pregnant Smokers: A Randomized Control Trial.

Authors:  Kathryn I Pollak; Pauline Lyna; Xiaomei Gao; Devon Noonan; Santiago Bejarano Hernandez; Sonia Subudhi; Geeta K Swamy; Laura J Fish
Journal:  Nicotine Tob Res       Date:  2020-06-12       Impact factor: 4.244

4.  Does moralization motivate smokers to quit? A longitudinal study of representative samples of smokers in the United States and Denmark.

Authors:  Marie Helweg-Larsen
Journal:  Nicotine Tob Res       Date:  2014-06-06       Impact factor: 4.244

5.  Unique Patterns of Substance Misuse associated with PTSD, Depression, and Social Phobia.

Authors:  Meghan E McDevitt-Murphy; James G Murphy; Christopher M Monahan; Amanda M Flood; Frank W Weathers
Journal:  J Dual Diagn       Date:  2010-04-01

Review 6.  The genetic components of alcohol and nicotine co-addiction: from genes to behavior.

Authors:  Isabel R Schlaepfer; Nicole R Hoft; Marissa A Ehringer
Journal:  Curr Drug Abuse Rev       Date:  2008-06

7.  Substance use behaviors as a mediator between posttraumatic stress disorder and physical health in trauma-exposed college students.

Authors:  Amanda M Flood; Meghan E McDevitt-Murphy; Frank W Weathers; David E Eakin; Trisha A Benson
Journal:  J Behav Med       Date:  2009-01-13

8.  A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men.

Authors:  Yan Feng; Tianhua Niu; Houxun Xing; Xin Xu; Changzhong Chen; Shaojie Peng; Lihua Wang; Nan Laird; Xiping Xu
Journal:  Am J Hum Genet       Date:  2004-05-20       Impact factor: 11.025

9.  Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial.

Authors:  Christian D Fankhauser; Andres Affentranger; Beatrice Cortonesi; Urs Jeker; Markus Gass; Fabrizio Minervini; Georg Jung; Corina Christmann; Christine Brambs; Milo A Puhan; Ulrike Held
Journal:  Trials       Date:  2022-08-29       Impact factor: 2.728

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.